Granzyme M expressed by tumor cells promotes chemoresistance and EMT  in vitro  and metastasis  in vivo  associated with STAT3 activation

Huiru Wang; Qing Sun; Yanhong Wu; Lin Wang; Chunxia Zhou; Wenbo Ma; Youhui Zhang; Shengdian Wang; Shuren Zhang

doi:10.18632/oncotarget.3461

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Granzyme M expressed by tumor cells promotes chemoresistance and EMT in vitro and metastasis in vivo associated with STAT3 activation

Huiru Wang, Qing Sun, Yanhong Wu, Lin Wang, Chunxia Zhou, Wenbo Ma, Youhui Zhang, Shengdian Wang and Shuren Zhang _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2015; 6:5818-5831. https://doi.org/10.18632/oncotarget.3461

Metrics: PDF 2299 views | HTML 3639 views | ?

Abstract

Huiru Wang1, Qing Sun2, Yanhong Wu1, Lin Wang3, Chunxia Zhou1, Wenbo Ma1, Youhui Zhang1, Shengdian Wang4 and Shuren Zhang1

1 Department of Immunology, Cancer Hospital & Cancer Institute, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China

2 Department of Parasitology, Capital Medical University, Beijing, China

3 Department of Pathology, Cancer Hospital & Cancer Institute, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China

4 Center of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China

Correspondence to:

Shuren Zhang, email:

Keywords: cancer, granzyme M, chemoresistance, metastasis, epithelial-mesenchymal transition

Received: September 28, 2014 Accepted: January 22, 2015 Published: February 28, 2015

Abstract

Granzyme M is a serine protease known to be often expressed by natural killer cells and induce target cells apoptosis in combination with perforin. However, we detected granzyme M expression in murine and human cancer cell lines and human tumor samples in our study. Granzyme M increased chemoresistance, colony-formation, cytokine secretion and invasiveness in vitro. Most importantly, granzyme M facilitated tumor growth and metastasis in vivo. Granzyme M induced the epithelial-mesenchymal transition (EMT) in cancer cells associated with STAT3 activation. Our study revealed the role of granzyme M expressed by tumor in chemoresistance, invasion, metastasis and EMT.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 3461

Publication Alerts

Research Papers:

Granzyme M expressed by tumor cells promotes chemoresistance and EMT in vitro and metastasis in vivo associated with STAT3 activation

Abstract